Related Experiment Videos
Hepatic macrophage function in schistosomal glomerulopathy
R S Barsoum1, G Sersawy, S Haddad
1Faculty of Medicine, Cairo University, Egypt.
Summary
Hepatic macrophage dysfunction significantly contributes to schistosomal glomerulopathy, impacting kidney lesions and IgA deposits. Impaired immune cell function in the liver is key to understanding this kidney disease.
Area of Science:
- Immunology
- Nephrology
- Hepatology
Background:
- Hepatic fibrosis in schistosomal glomerulopathy is not solely due to liver cell damage.
- The role of impaired hepatic macrophage function requires investigation.
Purpose of the Study:
- To examine the potential role of impaired hepatic macrophage function in schistosomal glomerulopathy pathogenesis.
- To correlate hepatic macrophage function with clinical and pathological findings in glomerulopathy.
Main Methods:
- Studied plasma clearance of 99mTc-sulphur colloid (t1/2) in patients with schistosomal glomerulopathy and control groups.
- Analyzed liver and renal biopsies using light microscopy and glomerular immunofluorescence.
Main Results:
- Significant correlation found between sulphur colloid clearance t1/2 and proteinuria, mesangial hypercellularity, and IgA glomerular deposits.
- Hepatic macrophage dysfunction is linked to the severity and pattern of glomerular lesions.
Conclusions:
- Hepatic macrophage dysfunction is a crucial factor in schistosomal glomerulopathy pathogenesis.
- Immunoglobulin A (IgA) plays a significant role in advanced glomerular damage.
- Impaired hepatic macrophage function influences IgA clearance and the progression of kidney disease.